1B1 — Hc Surgical Specialists Income Statement
0.000.00%
Last trade - 00:00
- SG$39.99m
- SG$36.05m
- SG$18.81m
- 96
- 65
- 25
- 71
2020 May 31st | 2021 May 31st | 2022 May 31st | 2023 May 31st | 2024 May 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 16.7 | 23.4 | 19.3 | 19.1 | 18.8 |
Cost of Revenue | |||||
Gross Profit | 14.8 | 20.3 | 16.7 | 16.4 | 16 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 10.9 | 12.7 | 12.1 | 12.7 | 12.7 |
Operating Profit | 5.78 | 10.7 | 7.23 | 6.34 | 6.09 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4.82 | 10.3 | 7.75 | 4.05 | 5.06 |
Provision for Income Taxes | |||||
Net Income After Taxes | 4.04 | 8.85 | 6.8 | 2.98 | 3.94 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3.5 | 8 | 6.38 | 2.92 | 3.85 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3.5 | 8 | 6.38 | 2.92 | 3.85 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.027 | 0.048 | 0.045 | 0.025 | 0.025 |
Dividends per Share |